• Researchers Test Noninvasive Form of Deep Brain Stimulation on Mice
  • Cherish Life’s Fleeting Moments and Do Not Surrender
  • Development of Parkinson’s Disease Could Begin in Intestinal Cells, New Study Suggests
  • NTCELL Shows Promise as Cell Therapy for Parkinson’s Patients
  • Difficulty in Diagnosis Greatly Affects Quality of Life of Parkinson’s Patients, Survey Finds
  • Study Reviews Use of Acadia’s Nuplazid as Treatment for Psychosis Linked to Parkinson’s Disease
  • FDA Reviewing ADS-5102, Possible 1st Treatment for Levodopa-induced Dyskinesia in Parkinson’s
  • Parkinson’s Vaccine Triggers Solid Immune Response, Phase 1 Clinical Trial Shows
  • Muhammad Ali’s Death Had Huge Impact on Parkinson’s Disease Awareness, Survey Shows
  • An Introduction to ‘Journeying Through Parkinson’s Disease
,’ a Column by Sherri Woodbridge
  • EMA Accepts Phase 3 Trial Design of NeuroDerm’s Experimental Parkinson’s Treatment
  • ND0612H Eliminated Daily Symptoms-recurrence Periods for 42% of Parkinson’s Patients, Trial Shows